NASDAQ: TER
TERADYNE, INCCIK 0000097210 · SIC 3825 · Instruments for Measuring
Large
Revenue $3.2B
Assets $4.9B
as of Oct 18, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (EPM 10-K) is open in full — no account needed.
10-Q
Filed Oct 30, 2026
· Period ending Sep 27, 2026
Summary not yet generated.
8-K
Filed Oct 28, 2026
· Period ending Oct 27, 2026
Summary not yet generated.
Partner
Trade TER commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Aug 10, 2026
· Period ending Aug 7, 2026
Summary not yet generated.
10-Q
Filed Jul 31, 2026
· Period ending Jun 28, 2026
TER Q2 revenue doubles to $1.33B on AI compute/memory surge; acquires MLTP
5 material changes detected. Sign up free to read the summary.
8-K
Filed Jul 29, 2026
· Period ending Jul 28, 2026
Summary not yet generated.
8-K
Filed May 11, 2026
· Period ending May 8, 2026
Summary not yet generated.
10-Q
Filed May 1, 2026
· Period ending Mar 29, 2026
Summary not yet generated.
8-K
Filed Apr 29, 2026
· Period ending Apr 28, 2026
Summary not yet generated.
10-K
Filed Feb 19, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
10-Q
Filed Oct 30, 2025
· Period ending Sep 28, 2025
Summary not yet generated.
10-Q
Filed Aug 1, 2025
· Period ending Jun 29, 2025
Summary not yet generated.
10-K
Filed Feb 20, 2025
· Period ending Dec 31, 2024
Summary not yet generated.
Latest financial statements
From 10-Q filed Oct 30, 2026 (period ending Sep 27, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
(in thousands, except per share amount)
| Description | Three months ended September 27, 2026 | Three months ended September 28, 2025 | Nine months ended September 27, 2026 | Nine months ended September 28, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Products | 1,164,165 | 632,104 | 3,498,463 | 1,716,718 |
| Services | 141,785 | 137,106 | 418,971 | 389,969 |
| Total revenues | 1,305,950 | 769,210 | 3,917,434 | 2,106,687 |
| Cost of revenues: | ||||
| Cost of products | 485,092 | 270,634 | 1,425,757 | 727,198 |
| Cost of services | 49,582 | 49,270 | 144,831 | 141,834 |
| Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below) | 534,674 | 319,904 | 1,570,588 | 869,032 |
| Gross profit | 771,276 | 449,306 | 2,346,846 | 1,237,655 |
| Operating expenses: | ||||
| Selling and administrative | 198,968 | 169,144 | 558,224 | 484,182 |
| Engineering and development | 163,092 | 124,760 | 454,938 | 361,331 |
| Acquired intangible assets amortization | 5,251 | 3,514 | 12,447 | 11,820 |
| Restructuring and other | 1,997 | 6,585 | 8,455 | 23,472 |
| Total operating expenses | 369,308 | 304,003 | 1,034,064 | 880,805 |
| Income from operations | 401,968 | 145,303 | 1,312,782 | 356,850 |
| Non-operating (income) expense: | ||||
| Interest income | (3,341) | (3,191) | (8,945) | (12,618) |
| Interest expense | 868 | 1,309 | 6,983 | 2,909 |
| Other (income) expense, net | 150 | (915) | 1,156 | 2,875 |
| Income before income taxes and equity in net earnings of affiliate | 404,291 | 148,100 | 1,313,588 | 363,684 |
| Income tax provision | 59,833 | 23,344 | 188,778 | 50,148 |
| Income before equity in net earnings of affiliate | 344,458 | 124,756 | 1,124,810 | 313,536 |
| Equity in net earnings of affiliate | 3,281 | (5,198) | (3,277) | (16,709) |
| Consolidated net income | 347,739 | 119,558 | 1,121,533 | 296,827 |
| Less: Net income attributable to noncontrolling interests | 5,332 | — | 5,684 | — |
| Net income attributable to Teradyne | 342,407 | 119,558 | 1,115,849 | 296,827 |
| Earnings per common share attributable to Teradyne: | ||||
| Basic | 2.19 | 0.75 | 7.14 | 1.85 |
| Diluted | 2.17 | 0.75 | 7.08 | 1.85 |
| Weighted average common shares—basic | 156,262 | 158,595 | 156,381 | 160,021 |
| Weighted average common shares—diluted | 157,502 | 159,097 | 157,610 | 160,409 |
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands, except per share amount)
| Description | September 27, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | 460,742 | 293,751 |
| Marketable securities | 5,847 | 28,247 |
| Accounts receivable, less allowance for credit losses of $2,773 and $2,410 at September 27, 2026 and December 31, 2025, respectively | 1,110,798 | 786,913 |
| Inventories, net | 574,992 | 379,552 |
| Prepayments | 613,658 | 427,564 |
| Other current assets | 24,185 | 33,273 |
| Total current assets | 2,790,222 | 1,949,300 |
| Property, plant and equipment, net | 679,603 | 562,999 |
| Operating lease right-of-use assets, net | 121,652 | 76,635 |
| Marketable securities | 158,276 | 126,256 |
| Deferred tax assets | 311,092 | 275,265 |
| Retirement plans assets | 12,240 | 12,059 |
| Equity method investment | 518,559 | 537,098 |
| Other assets | 97,111 | 71,697 |
| Acquired intangible assets, net | 96,662 | 51,271 |
| Goodwill | 663,776 | 521,019 |
| Total assets | 5,449,193 | 4,183,599 |
| LIABILITIES | ||
| Current liabilities: | ||
| Accounts payable | 516,967 | 269,185 |
| Accrued employees’ compensation and withholdings | 261,288 | 254,973 |
| Deferred revenue and customer advances | 211,683 | 153,124 |
| Other accrued liabilities | 146,332 | 111,845 |
| Operating lease liabilities | 17,061 | 19,340 |
| Short-term debt | — | 200,000 |
| Income taxes payable | 188,105 | 106,740 |
| Total current liabilities | 1,341,436 | 1,115,207 |
| Retirement plans liabilities | 152,910 | 144,874 |
| Long-term deferred revenue and customer advances | 58,342 | 50,888 |
| Deferred tax liabilities | 10,841 | 5,378 |
| Long-term other accrued liabilities | 28,649 | 7,601 |
| Long-term operating lease liabilities | 120,054 | 63,899 |
| Total liabilities | 1,712,232 | 1,387,847 |
| Commitments and contingencies (Note R) | ||
| Redeemable noncontrolling interests | 49,065 | — |
| EQUITY | ||
| Common stock, $0.125 par value, 1,000,000 shares authorized; 156,150 and 156,088 shares issued and outstanding at September 27, 2026, and December 31, 2025, respectively | 19,519 | 19,511 |
| Additional paid-in capital | 2,043,937 | 1,989,911 |
| Accumulated other comprehensive (loss) gain | 5,538 | 41,895 |
| Retained earnings | 1,618,902 | 744,435 |
| Total Teradyne shareholders’ equity | 3,687,896 | 2,795,752 |
| Total liabilities, redeemable noncontrolling interests, and equity | 5,449,193 | 4,183,599 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
| Description | Nine months ended September 27, 2026 | Nine months ended September 28, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Consolidated net income | 1,121,533 | 296,827 |
| Adjustments to reconcile consolidated net income from operations to net cash provided by operating activities: | ||
| Depreciation | 90,256 | 79,484 |
| Stock-based compensation | 63,649 | 47,561 |
| Equity in net earnings of affiliate | 3,277 | 16,709 |
| Amortization | 12,925 | 12,723 |
| Provision for excess and obsolete inventory | 19,213 | 19,175 |
| Losses (gains) on investments | (7,076) | (4,722) |
| Deferred taxes | (41,163) | (29,100) |
| Retirement plan losses (gains) | (228) | (673) |
| Other | 3,757 | 3,344 |
| Changes in operating assets and liabilities, net of businesses acquired: | ||
| Accounts receivable | (302,733) | (111,787) |
| Inventories | (178,794) | (34,618) |
| Prepayments and other assets | (224,940) | (22,599) |
| Accounts payable and other liabilities | 347,615 | 121,447 |
| Deferred revenue and customer advances | 64,045 | 25,652 |
| Retirement plans contributions | (4,605) | (6,986) |
| Income taxes | 81,144 | (19,661) |
| Net cash provided by operating activities | 1,047,875 | 392,776 |
| Cash flows from investing activities: | ||
| Purchases of property, plant and equipment | (241,762) | (161,121) |
| Acquisition of businesses, net of cash and cash equivalents acquired | (165,611) | (144,380) |
| Purchase of investment in a business | (20,900) | (25,519) |
| Purchases of marketable securities | (50,004) | (27,465) |
| Proceeds from maturities of marketable securities | 11,880 | 41,621 |
| Proceeds from sales of marketable securities | 30,607 | 9,172 |
| Net cash used for investing activities | (435,790) | (307,692) |
| Cash flows from financing activities: | ||
| Proceeds from borrowings on revolving credit facility | 350,000 | 200,000 |
| Repayments of borrowings on revolving credit facility | (550,000) | — |
| Dividend payments | (61,024) | (57,574) |
| Repurchase of common stock | (173,502) | (518,658) |
| Debt issuance costs | (2,686) | — |
| Payments related to net settlement of employee stock compensation awards | (42,153) | (15,254) |
| Issuance of common stock under stock purchase and stock option plans | 33,708 | 30,076 |
| Net cash used for financing activities | (445,657) | (361,410) |
| Effects of exchange rate changes on cash and cash equivalents | 563 | (4,328) |
| (Decrease) increase in cash and cash equivalents | 166,991 | (280,654) |
| Cash and cash equivalents at beginning of period | 293,751 | 553,354 |
| Cash and cash equivalents at end of period | 460,742 | 272,700 |
| Non-cash investing activities: | ||
| Capital expenditures incurred but not yet paid: | 12,292 | 7,821 |
Amounts as printed on the EDGAR/iXBRL face — (in thousands, except per share amount); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗